Systemic alendronate prevents resorption of necrotic bone during revascularization. A bone chamber study in rats

Por Aspenberg Per, Åstrand Jörgen
Publicado em 2002-08-01

Systemic alendronate prevents resorption of necrotic bone during revascularization. A bone chamber study in rats

Por Åstrand, Jörgen, Aspenberg, Per
Publicado em 2002

Screening for osteoporosis reduced new fracture incidence by almost half: A 6-year follow-up of 592 fracture patients from an osteoporosis screening program

Por Åstrand, Jörgen, Nilsson, Johan, Thorngren, Karl-Göran
Publicado em 2012

Systemic zoledronate treatment both prevents resorption of allograft bone and increases the retention of new formed bone during revascularization and remodelling. A bone chamber st...

Por Åstrand, Jörgen, Harding, Anna Kajsa, Aspenberg, Per, Tägil, Magnus
Publicado em 2006